128 related articles for article (PubMed ID: 3477298)
1. Bone marrow matrix modulation of HL-60 phenotype.
Luikart SD; Sackrison JL; Maniglia CA
Blood; 1987 Oct; 70(4):1119-23. PubMed ID: 3477298
[TBL] [Abstract][Full Text] [Related]
2. A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro.
Luikart SD; Maniglia CA; Furcht LT; McCarthy JB; Oegema TR
Cancer Res; 1990 Jun; 50(12):3781-5. PubMed ID: 2140291
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow extracellular matrix induces HL-60 cells to produce an autonomous differentiation factor.
Mane S; Winkelmann JC; Luikart SD
Cell Growth Differ; 1991 Dec; 2(12):637-43. PubMed ID: 1809376
[TBL] [Abstract][Full Text] [Related]
4. Effect of direct cell-to-cell interaction between the KM-102 clonal human marrow stromal cell line and the HL-60 myeloid leukemic cell line on the differentiation and proliferation of the HL-60 line.
Ohkawa H; Harigaya K
Cancer Res; 1987 Jun; 47(11):2879-82. PubMed ID: 3471319
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-associated hematopoiesis: immortalization and characterization of a primate bone marrow-derived stromal cell line.
Paul SR; Yang YC; Donahue RE; Goldring S; Williams DA
Blood; 1991 Apr; 77(8):1723-33. PubMed ID: 2015398
[TBL] [Abstract][Full Text] [Related]
6. Growth of human bone marrow in vitro.
Svet-Moldavsky I; Gulati SC; Clarkson B
Cell Biol Int Rep; 1985 Sep; 9(9):833-40. PubMed ID: 3876165
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
8. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of development of characteristic indices of myeloid differentiation by a factor released from a tetraploid variant of the human promyelocytic cell line, HL-60.
Mendelsohn N; Calderon T; Acs G; Christman JK
Exp Cell Res; 1983 Oct; 148(2):514-9. PubMed ID: 6605257
[TBL] [Abstract][Full Text] [Related]
10. Multiplication of human fetal myelomonocytic precursors in medium conditioned by acute myelocytic leukemia cells treated by 12-O-tetradecanoyl phorbol 13-acetate (TPA).
Svet-Moldavsky IA; Den T; Bowers CH; Wroblesky H
Biomed Pharmacother; 1985; 39(9-10):472-7. PubMed ID: 3869046
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation.
Grant S; Bhalla K; Weinstein B; Pestka S; Mileno MD; Fisher PB
Biochem Biophys Res Commun; 1985 Jul; 130(1):379-88. PubMed ID: 3861180
[TBL] [Abstract][Full Text] [Related]
12. A phorbol ester tolerant (PET) variant of HL-60 promyelocytes.
Macfarlane DE; Gailani D; Vann K
Br J Haematol; 1988 Mar; 68(3):291-302. PubMed ID: 3162684
[TBL] [Abstract][Full Text] [Related]
13. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA).
Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN
Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid promotes phorbol ester-initiated macrophage differentiation in HL-60 leukemia cells without disappearance of protein kinase C.
Zylber-Katz E; Knode MC; Glazer RI
Leuk Res; 1986; 10(12):1425-32. PubMed ID: 3099098
[TBL] [Abstract][Full Text] [Related]
17. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
Chen ZX; Wang W; Wu WL
Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
[TBL] [Abstract][Full Text] [Related]
18. Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells.
Gowda SD; Koler RD; Bagby GC
J Clin Invest; 1986 Jan; 77(1):271-8. PubMed ID: 3511091
[TBL] [Abstract][Full Text] [Related]
19. The effect of glutathione on HL-60 treated with dimethylsulfoxide, butyric acid or 12-O-tetradecanoylphorbol-13-acetate.
Zucker RM; Whittington KB; Decal DL
FEBS Lett; 1983 May; 155(1):107-12. PubMed ID: 6573264
[TBL] [Abstract][Full Text] [Related]
20. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
